As the sale of weight loss drugs skyrocket around the country, Illinois’ attorney general is saying buyer beware. Sales of weight loss drugs like Ozempic and Wegovy have soared, with over 1.6 million prescriptions issued in Illinois last year,

Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would drugmakers agree to reduce their prices right away?

GLP-1 weight-loss drugs such as Ozempic and Wegovy are driving down grocery spending, according to a new study from Cornell’s SC Johnson College of Business and consumer data firm Numerator.

Higher-income households with at least one user of GLP-1 class of weight loss drugs cut their grocery spending by nearly 9%, a recent study based on data from the market research firm Numerator indicates.